Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
ID: 350415Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $300K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Cancer Research Education Grants Program, specifically the R25 initiative, to support educational activities focused on skill development in biomedical, behavioral, and clinical research related to cancer. This program aims to foster innovative and evidence-based curricula that address critical topics such as cancer prevention, diagnosis, treatment, and rehabilitation, thereby enhancing the training of a skilled workforce to meet national research needs. Eligible applicants include a diverse range of institutions, including higher education entities, nonprofits, and various governmental organizations, with a maximum funding amount of $300,000 per year for up to five years. Interested parties should submit their applications through Grants.gov by the closing date of January 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The NIH Cancer Research Education Grants Program, specifically the R25 initiative, aims to support educational activities focused on skill development within biomedical, behavioral, and clinical research related to cancer. The program encourages innovative, evidence-based curricula addressing cancer-related topics such as prevention, diagnosis, and rehabilitation. The grant allows a maximum of $300,000 in direct costs per year for up to five years, emphasizing a clear proposal with distinct objectives that enhance the existing research training framework. Eligible applicants include higher education institutions, nonprofits, and various governmental entities, with a strong encouragement for diversity in recruitment. Applications must comply with stringent guidelines regarding course focus and evaluation criteria, ensuring that projects proposed not replicate existing NIH efforts and address relevant educational needs. The review process evaluates significance, innovation, approach, and environment, with particular attention to the broader impact on cancer research training. The application process is facilitated through Grants.gov and must follow the specified timelines and requirements for consideration. This funding opportunity symbolizes the NIH's commitment to fostering a skilled workforce in cancer research education.
    Similar Opportunities
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) to enhance education and training in cancer research. This program aims to support innovative educational activities that address various aspects of cancer, including its causes, prevention, treatment, and rehabilitation, with a focus on developing a skilled workforce to meet national biomedical research needs. Eligible applicants include a diverse range of institutions such as Historically Black Colleges and Universities, Hispanic-serving Institutions, and community-based organizations, with a maximum funding amount of $300,000 per year. Applications will be accepted starting December 25, 2023, with recurring deadlines until January 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled the National Cancer Institute Youth Enjoy Science Research Education Program (R25), aimed at enhancing research education for students from diverse backgrounds, particularly those underrepresented in biomedical and behavioral sciences. This program supports educational activities that focus on providing research experiences, curriculum development, and outreach initiatives to engage middle and high school students, as well as undergraduates, in cancer research. The initiative is crucial for addressing disparities in cancer research representation and inspiring future generations in the field. Eligible applicants can receive up to $400,000 annually for a project period of up to five years, with applications due by September 28, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-026.html.
    NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for Research Education Programs (R25), aimed at enhancing training for the biomedical, behavioral, and clinical research workforce. This grant supports innovative educational activities focused on research skills development, with a funding ceiling of $150,000 per year for a maximum of five years, and is not intended for clinical trials. The initiative emphasizes the importance of creating accessible educational opportunities that foster diversity and collaboration among participants, ranging from upper undergraduates to faculty. Interested applicants can find more information and application guidelines at the provided link, with proposals due by May 25, 2025, and inquiries directed to grantsinfo@nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering exploratory grants (R21 Clinical Trial Optional) aimed at advancing cancer control research. This funding opportunity encourages innovative approaches to understanding cancer etiology, behavior modification, and screening techniques, focusing on the early stages of impactful research that can significantly enhance population-based cancer research. Grants will provide up to $275,000 over two years, with a maximum of $200,000 available in a single year, and applications are due by October 8, 2024. Interested applicants can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the NCI Small Grants Program for Cancer Research (R03) for the years 2023 to 2025. This funding opportunity is designed to support small-scale research projects on cancer that can be completed within a two-year timeframe and with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies or technologies. Grants of up to $50,000 per year are available to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations. Interested parties should submit their applications electronically via Grants.gov, with the first submission deadline having been January 22, 2023, and subsequent deadlines continuing through 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), has announced a funding opportunity titled "NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)" aimed at enhancing research education in biomedical, behavioral, and clinical research. This initiative seeks applications for innovative educational activities that provide hands-on research experiences and skills development, particularly in the field of neuroscience, with a maximum funding of $250,000 per year for up to five years. The program emphasizes diversity recruitment and significant institutional commitment, requiring applicants to include a comprehensive evaluation plan and adhere to strict guidelines. Interested parties can find more information and apply by July 14, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering Research Education Program Grants (R25) to enhance training in biomedical, behavioral, and clinical research. This funding opportunity aims to support educational activities that develop research skills and provide hands-on experiences in areas critical to NIDDK, including diabetes, digestive diseases, and obesity. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and local governments, with a funding limit of $100,000 per year for up to five years. The application deadline is January 30, 2024, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html.